Authors:
BREISTOL K
HENDRIKS HR
BERGER DP
LANGDON SP
FIEBIG HH
FODSTAD O
Citation: K. Breistol et al., THE ANTITUMOR-ACTIVITY OF THE PRODRUG N-L-LEUCYL-DOXORUBICIN AND ITS PARENT COMPOUND DOXORUBICIN IN HUMAN TUMOR XENOGRAFTS, European journal of cancer, 34(10), 1998, pp. 1602-1606
Authors:
VOORN DA
KUIPER CM
NOORDHUIS P
SMID K
SANDVOLD ML
MYHREN F
HENDRIKS HR
PETERS GJ
Citation: Da. Voorn et al., BIOLOGIC ACTIVITY OF LIPOPHILIC 1-B-D-ARABINOFURANOSYLCYTOSINE (ARA-C) DERIVATIVES - CELL-SPECIFIC CYTOTOXICITY AND STRUCTURE-ACTIVITY RELATIONSHIP (SAR), Annals of oncology, 9, 1998, pp. 119-119
Authors:
HENDRIKS HR
BURTLES S
RADTKE S
SCHULTZ RJ
DOUBLE JA
SAUSVILLE EA
NEWELL DR
Citation: Hr. Hendriks et al., CELL-BASED SCREENING AND PHARMACOLOGICAL STRATEGIES FOR THE SELECTIONOF NEW ANTICANCER AGENTS - A COLLABORATION BETWEEN THE NATIONAL-CANCER-INSTITUTE (NCI), CANCER-RESEARCH CAMPAIGN (CRC) AND EORTC, Annals of oncology, 9, 1998, pp. 155-155
Citation: I. Fichtner et Hr. Hendriks, IMMUNOMODULATING ACTIVITY OF OM-174, A CHEMICALLY-DEFINED 3,3'-O-DEACYLATED ESCHERICHIA-COLI LIPID-A, Annals of oncology, 9, 1998, pp. 330-330
Authors:
MASTERS JRW
KNOW RJ
HARTLEY JA
KELLAND LR
HENDRIKS HR
CONNORS T
Citation: Jrw. Masters et al., KW-2149 2-[Y-L-GLUTAMYLAMINO]ETHYLDITHIOETHYL]MITOMYCIN-C) - A NEW MITOMYCIN-C ANALOG ACTIVATED BY SERUM, Biochemical pharmacology, 53(3), 1997, pp. 279-285
Citation: E. Smitskampwilms et al., DEVELOPMENT, PHARMACOLOGY, ROLE OF DT-DIAPHORASE AND PROSPECTS OF THEINDOLOQUINONE EO9, General pharmacology, 27(3), 1996, pp. 421-429
Citation: D. Gaal et Hr. Hendriks, EFFECT OF OM-163, A NEW BIOLOGICAL RESPONSE MODIFIER ON THE IMMUNO-SUPPRESSION CAUSED BY CYTOSTATICS AND IONIZING-RADIATION, European journal of cancer, 31A, 1995, pp. 593-593
Authors:
DREES N
DENGLER WM
HENDRIKS HR
KELLAND LR
FIEBIG HH
Citation: N. Drees et al., CYCLOPLATAM - A NOVEL PLATINUM COMPOUND EXHIBITING A DIFFERENT SPECTRUM OF ANTITUMOR-ACTIVITY TO CISPLATIN, European journal of cancer, 31A(3), 1995, pp. 356-361
Authors:
LANGDON SP
HENDRIKS HR
BRAAKHUIS BJM
PRATESI G
BERGER DP
FODSTAD O
FIEBIG HH
BOVEN E
Citation: Sp. Langdon et al., PRECLINICAL PHASE-II STUDIES IN HUMAN TUMOR XENOGRAFTS - A EUROPEAN MULTICENTER FOLLOW-UP-STUDY, Annals of oncology, 5(5), 1994, pp. 415-422
Authors:
SILVESTRINI R
ZAFFARONI N
COSTA A
ORLANDI L
VILLA R
HENDRIKS HR
Citation: R. Silvestrini et al., FLUNARIZINE AS A MODULATOR OF DOXORUBICIN RESISTANCE IN HUMAN COLON-ADENOCARCINOMA CELLS, International journal of cancer, 55(4), 1993, pp. 636-639